Large-cap Health Care company ResMed has logged a -2.8% change today on a trading volume of 844,074. The average volume for the stock is 1,644,378.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. Based in San Diego, United States the company has 10,140 full time employees and a market cap of $20,961,081,344. ResMed currently offers its equity investors a dividend that yields 1.2% per year.
The company is now trading -22.55% away from its average analyst target price of $184.0 per share. The 8 analysts following the stock have set target prices ranging from $165.0 to $220.0, and on average give ResMed a rating of buy.
Over the last 12 months RMD shares have declined by -38.0%, which represents a difference of -49.0% when compared to the S&P 500. The stock's 52 week high is $243.52 per share and its 52 week low is $136.02. Based on ResMed's average net margin growth of 4.2% over the last 6 years, its core business remains strong and the stock price may recover in the long term.
|Date Reported||Total Revenue ($ k)||Net Profit ($ k)||Net Margins (%)||YoY Growth (%)|